ChemicalBook > CAS DataBase List > Paricalcitol
Paricalcitol
Paricalcitol
- CAS No.131918-61-1
- Chemical Name:Paricalcitol
- CBNumber:CB0500520
- Molecular Formula:C27H44O3
- Formula Weight:416.65
- MOL File:131918-61-1.mol
Paricalcitol Property
- Boiling point 564.8±50.0 °C(Predicted)
- Density 1.121±0.06 g/cm3(Predicted)
- Flash point 14℃
- storage temp. Store at -20°C,unstable in solution, ready to use.
- solubility DMSO : 100 mg/mL (240.02 mM; Need ultrasonic)Ethanol : 12.5 mg/mL (30.00 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- pka 14.34±0.40(Predicted)
- form Solid
- color White to off-white
- InChIKey BPKAHTKRCLCHEA-UBFJEZKGSA-N
- SMILES C[C@]12CCC/C(=C\C=C3C[C@@H](O)C[C@H](O)C3)/[C@]1([H])CC[C@]2([H])[C@H](C)/C=C/[C@H](C)C(O)(C)C |&1:1,10,13,16,20,22,26,r|
- CAS DataBase Reference 131918-61-1(CAS DataBase Reference)
- FDA UNII 6702D36OG5
- NCI Dictionary of Cancer Terms paricalcitol
- NCI Drug Dictionary paricalcitol
- ATC code H05BX02
- UNSPSC Code 41116107
- NACRES NA.77
Safety
- RIDADR :UN1170 - class 3 - PG 2 - Ethanol, solution
- HS Code :2936299055
- Hazardous Substances Data :131918-61-1(Hazardous Substances Data)
-
NFPA 704:
0 4 0
-
Symbol(GHS)
- Signal wordDanger
- Hazard statements H301+H311-H330-H372
- Precautionary statements P280-P301+P310+P330-P302+P352+P312-P304+P340+P310-P314
Paricalcitol Chemical Properties,Usage,Production
- Description Paricalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo.
- Description Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.
- Chemical Properties White Solid
- Originator Abbott (US)
- Uses Antihyperparathyriod
- Uses 1,25-Dihydroxy vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.
- Uses Synthetic analog of vitamin D. Antihyperparathyroid.
- Definition ChEBI: Paricalcitol is a seco-cholestane and a hydroxy seco-steroid. It has a role as an antiparathyroid drug. It is functionally related to a vitamin D2.
- brand name Zemplar (Abbott).
-
Clinical Use
Vitamin D analogue:
Treatment and prevention of secondary hyperparathyroidism associated with chronic renal failure -
Metabolism
Extensively metabolised via hepatic and non-hepatic
pathways to form two relatively inactive metabolites.
After oral administration of 3
H-paricalcitol, only about
2% of the dose was eliminated unchanged in the faeces,
and no parent drug found in the urine.
Approximately 70% of the radioactivity was eliminated in the faeces and 18% was recovered in the urine. Most of the systemic exposure was from the parent drug.
Paricalcitol Preparation Products And Raw materials
Raw materials
Preparation Products
Global(273)Suppliers
-
Supplier:
- Tel: +8618523575427
- Email:sales@conier.com
- Country:China
- ProdList:49732
- Advantage:58
-
Supplier:
- Tel:+86-18353166132<br/>+86-18353166132
- Email:sales02@airuikechemical.com
- Country:China
- ProdList:983
- Advantage:58
-
Supplier:
- Tel: +8618882027439
- Email:sales2@runyanpharma.com
- Country:China
- ProdList:302
- Advantage:58
-
Supplier:
- Tel:+86-(0)57185586718<br/>+86-13336195806
- Email:sales@capot.com
- Country:China
- ProdList:29730
- Advantage:60
-
Supplier:
- Tel:+86-371-+86-371-66670886
- Email:info@dakenam.com
- Country:China
- ProdList:19805
- Advantage:58
-
Supplier:
- Tel:+86-0371-55170693<br/>+86-19937530512
- Email:info@tianfuchem.com
- Country:China
- ProdList:21628
- Advantage:55
-
Supplier:
- Tel:18017610038
- Email:zheyansh@163.com
- Country:CHINA
- ProdList:3619
- Advantage:58
-
Supplier:
- Tel:0086-13720134139
- Email:candy@biochempartner.com
- Country:CHINA
- ProdList:965
- Advantage:58
-
Supplier:
- Tel:18871490254
- Email:linda@hubeijusheng.com
- Country:CHINA
- ProdList:28172
- Advantage:58
-
Supplier:
- Tel:+1-631-485-4226
- Email:inquiry@bocsci.com
- Country:United States
- ProdList:19552
- Advantage:58
131918-61-1, ParicalcitolRelated Search:
- Matrine Zoledronic acid Argatroban 2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol (((1R,3R)-5-(2-chloroethylidene)cyclohexane-1,3-diyl)bis(oxy)) bis(tert-butyldimethylsilane) tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl -6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl) -7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane Calcium dobesilate Entacapone Emtricitabine Sofosbuvir Sevelamer hydrochloride (R)-(3-hydroxy-2,3-diMethylbutyl)triphenylphosphoniuM iodide Vitamin D2 Calcifediol Monohydrate Secalciferol Paricalcitol Solution Paricalcitol 1(ALPHA) 25-DIHYDROXYVITAMIN D2*
- 131918-61-1
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Chiral Reagents
- Vitamin D3 analogs
- 信号转导通路激酶抑制剂
- 杂质对照品
- 抑制剂
- 医药化学试剂
- 代谢物
- 标准品
- 化学试剂
- 精品科研试剂
- 000-中间体
- 其它中间体
- 医药原药
- 有机中间体
- 甲状旁腺功能亢进治疗药
- 原料药
- 医药原料
- 抗肿瘤类
- 131919-61-1
- (1R,3R)-5-(2-((1R,3AS,7AR,E)-1-((2R,5S,E)-6-羟基-5,6-二甲基庚-3-烯-2-基)-7-甲基八氢-4H-茚-4-亚基)亚乙基)环己烷-1,3-二醇
- 优选]PARICALCITOL
- (1R,3R)-5-((E)-2-((1R,3AS,7AR)-1-((2R,5S,E)-6-羟基-5,6-二甲基庚-3-烯-2-基)-7A-甲基六氢-1H-茚-4(2H)-亚基)亚乙基)环己烷-1,3-二醇
- 干冰运输][2H6]-帕立骨化醇
- 帕立骨化醇/PARICALCITOL
- 2,5-双羟基维他命D2
- 帕立骨化醇 USP标准品
- 帕里醇
- 帕立骨化醇 5MG
- 1,25-双羟基维他命D2
- 帕立骨化醇
- 帕立骨化醇(冷藏运输)
- 131918-61-1
- (1R,3R)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol
- Zemplarr
- Paricalciferol
- (1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diol
- Zemplar
- CS-1390
- Paricalcitol (COLD SHIPMENT REQUIRED) (1499403)
- ParicalcitolQ: What is Paricalcitol Q: What is the CAS Number of Paricalcitol Q: What is the storage condition of Paricalcitol Q: What are the applications of Paricalcitol
- (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
- 19-Nor-1,25- dihydroxyvitaMin D2
- (1α,3β,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol
- (1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
- Paricalcitol (10 mg) (COLD SHIPMENT REQUIRED)
- Paricalcitol(Zemplar)
- 1,25-DihydroxyvitaMin D2 Paricalcitol
- Paricalcitol, >=98%
- 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R,5Z)-
- (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
- 19-nor-1alpha,25-dihydroxyvitamin D2
- PARICALCITOL
- PARICALCITOL (10 MG)F0E3030.997MG/MG(AI)
- Paricalcitol/ 19-nor-1α,25-dihydroxyergocalciferol
- 1α,25-Dihydroxy-19-nor-vitaMin D2